Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 468, Issue 1, 2000, Pages 87-92

  Ni, Zuyao ^a,b   Liu, Yu Qing ^b   Keshava, Nagalakshmi ^a   Zhou, Gu ^a   Whong, Wen Zong ^a   Ong, Tong Man ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Asbestos; K ras proto oncogene; Mesotheliomas; p53 tumor suppressor gene

Indexed keywords

ASBESTOS; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PRIORITY JOURNAL; RAT; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ANIMALS; ASBESTOS; BASE SEQUENCE; CARCINOGENS; DNA MUTATIONAL ANALYSIS; DNA RESTRICTION ENZYMES; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, RAS; HUMANS; MALE; MESOTHELIOMA; MUTATION; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RATS; RATS, WISTAR;

EID: 0034702353     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00043-7     Document Type: Article

References (32)

1. Reynolds T. Asbestos-linked cancer rates up less than predicted: news and commentary. J. Natl. Cancer Inst. 84:1992;560-562.
2. Wagner J.C., Sleggs C.A., Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br. J. Ind. Med. 17:1960;260-271.
3. Libbus B.L., Craighead J.E. Chromosomal translocations with specific breakpoints in asbestos-induced rat mesotheliomas. Cancer Res. 48:1988;6455-6461.
4. Popescu N.C., Chahinian A.P., DiPaolo J.A. Non-random chromosome alterations in human malignant mesothelioma. Cancer Res. 48:1988;142-147.
5. Selikoff I.J., Hammond E.C., Seidman H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer. 46:1980;2736-2740.
6. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
7. Almoguera C., Shibata D., Forrester K., Martin J., Arnheim N., Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 53:1988;549-554.
8. Bos J.L., Fearon E.R., Hamilton S.R., Verlaan-de Vries M., van Boom J.H., van der Eb A.J., Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature. 327:1987;293-297.
9. Salgia R., Skarin A.T. Molecular abnormalities in lung cancer. J. Clin. Oncol. 16:1998;1207-1217.
10. Levine A.J. The p53 tumor-suppressor gene. N. Engl. J. Med. 326:1992;1350-1352.
11. Cote R.J., Jhanwar S.C., Novick S., Pellicer A. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cancer Res. 51:1991;5410-5416.
12. Kitamura F., Araki S., Tanigawa T., Miura H., Akabane H., Iwasaki R. Assessment of mutations of Ha- and Ki-ras oncogenes and the p53 suppressor gene in seven malignant mesothelioma patients exposed to asbestos - PCR-SSCP and sequencing analyses of paraffin-embedded primary tumors. Ind. Health. 36:1998;52-56.
13. Mor O., Yaron P., Huszar M., Yellin A., Jakobovitz O., Brok-Simoni F., Rechavi G., Reichert N. Absence of p53 mutations in malignant mesotheliomas. Am. J. Respir. Cell Mol. Biol. 16:1997;9-13.
14. Metcalf R.A., Welsh J.A., Bennett W.P., Seddon M.B., Lehman T.A., Pelin K., Linnainmaa K., Tammilehto L., Mattson K., Gerwin B.I.et al. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res. 52:1992;2610-2615.
15. Liu B.C., Fu D.C., Miao Q., Wang H.H., You B.R. p53 gene mutations in asbestos associated cancers. Biomed. Environ. Sci. 11:1998;226-232.
16. Jacobson D.R., Mills N.E. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene. 9:1994;553-563.
17. Tiainen M., Kere J., Tammilehto L., Mattson K., Knuutila S. Abnormalities of chromosomes 7 and 22 in human malignant pleural mesothelioma: correlation between Southern blot and cytogenetic analyses. Genes, Chromosomes Cancer. 4:1992;176-182.
18. Kafiri G., Thomas D.M., Shepherd N.A., Krausz T., Lane D.P., Hall P.A. p53 expression is common in malignant mesothelioma. Histopathology. 21:1992;331-334.
19. Segers K., Backhovens H., Singh S.K., De Voecht J., Ramael M., Van Broeckhoven C., Van Marck E. Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma. Virchows Arch. 427:1995;431-436.
20. Ramael M., Deblier I., Eerdekens C., Lemmens G., Jacobs W., VanMarck E. Immunohistochemical staining of ras oncogene product in neoplastic and non-neoplastic mesothelial tissues: immunoreactivity for N-ras and lack of immunohistochemical staining for Ha-ras and K-ras. J. Pathol. 169:1993;421-424.
21. Kishimoto T. The distribution of various type of oncogenes products in the tumor tissue of malignant mesothelioma. Nihon Kyobu Shikkan Gakkai Zasshi. 29:1991;1168-1173.
22. Carbone M., Rizzo P., Grimley P.M., Procopio A., Mew D.J., Shridhar V., de Bartolomeis A., Esposito V., Giuliano M.T., Steinberg S.M., Levine A.S., Giordano H.I. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat. Med. 3:1997;908-912.
23. Levresse V., Moritz S., Renier A., Kheuang L., Galateau-Salle F., Mege J.P., Piedbois P., Salmons B., Guenzburg W., Jaurand M.C. Effect of simian virus large T antigen expression on cell cycle control and apoptosis in rat pleural mesothelial cells exposed to DNA damaging agents. Oncogene. 16:1998;1041-1053.
24. Jensen C.G., Jensen L.C., Rieder C.L., Cole R.W., Ault J.G. Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis. Carcinogenesis. 17:1996;2013-2021.
25. Yegles M., Saint-Etienne L., Renier A., Janson X., Jaurand M.C. Induction of metaphase and anaphase/telophase abnormalities by asbestos fibers in rat pleural mesothelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 9:1993;186-191.
26. Dong H., Buard A., Renier A., Levy F., Saint-Etienne L., Jaurand M.C. Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro. Carcinogenesis. 15:1994;1251-1255.
27. Hardy J.A., Aust A.E. Iron in asbestos chemistry and carcinogenicity. Chem. Rev. 95:1995;97-118.
28. Kamp D.W., Graceffa P., Pryor W.A., Weitzman S.A. The role of free radicals in asbestos-induced diseases. Free Radical Biol. Med. 12:1992;293-315.
29. Lechner J.F., Tokiwa T., LaVeck M., Benedict W.F., Banks-Schlegel S., Yeager H. Jr., Banerjee A., Harris C.C. Asbestos-associated chromosomal changes in human mesothelial cells. Proc. Natl. Acad. Sci. U. S. A. 82:1985;3884-3888.
30. Linnainmaa K., Gerwin B.I., Pelin K., Jantuene K., LaVeck M.A., Lechner J.F., Harris C.C. Asbestos-induced mesothelioma and chromosomal abnormalities in humanmesothelial cell in in vitro. The Changing Nature of Work and Work Place. 1986;119-122 NIOSH, Cincinnati, OH.
31. Wang N.S., Jaurand M.C., Magne L., Kheuang L., Pinchon M.C., Bignon J. The interactions between asbestos fibers and metaphase chromosomes of rat pleural mesothelial cells in culture: a scanning and transmission electron microscopic study. Am. J. Pathol. 126:1987;343-349.
32. Pelin K., Hirvonen A., Taavitsainen M., Linnainmaa K. Cytogenetic response to asbestos fibers in cultured human primary mesothelial cells from 10 different donors. Mutat Res. 334:1995;225-233.